Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

Summary

The goal of this mechanistic clinical trial is to test the effects of reducing inflammatory signaling in femoral artery atherosclerotic plaques. Researchers will compare patients receiving colchicine to patients receiving placebo to determine the effect of colchicine on the inflammatory state of atherosclerotic femoral arteries.

Timeline

Start

2024-09-25

Primary completion

2026-03-25

Completion

2026-03-25

Drugs

Indications